healthcare services / weak healthcare infrastructures / driven distribution chain / manufacturing / treatment of the three diseases / distribution chain / pharmaceutical / healthcare capacity / pharmaceutical industry / treatment of HIV / health care infrastructure / AIDS care / therapies for HIV / investments in researching new products / vaccines distribution chain / /
United Nations International Children's Emergency Fund / World Trade Organization / UK government / World Health Organization / United Nations / UNAIDS / G7 / European Commission / /
GUNTHER FABER WTO/WHO PRESENTATION: OSLO, 9 APRIL 2001 GlaxoSmithKline is determined to play its full part in improving access to medicines for the world’s poorest people. The company is acutely aware of the unacceptab